氟尼酸产品图

氟尼酸

收藏
  • ¥140 - 2331
  • Solarbio已认证
  • 北京
  • IN1830
  • 2026年08月13日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 保存条件

      Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year

    • 保质期

      Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year

    • 英文名

      Niflumic Acid

    • 库存

      999

    • 供应商

      北京索莱宝科技有限公司

    • CAS号

      4394-00-7

    • 规格

      100mg/5mg/10mg/25mg/50mg/200mg/500mg/1g

    规格:100mg产品价格:¥550.00
    规格:5mg产品价格:¥140.00
    规格:10mg产品价格:¥210.00
    规格:25mg产品价格:¥320.00
    规格:50mg产品价格:¥480.00
    规格:200mg产品价格:¥880.00
    规格:500mg产品价格:¥1545.00
    规格:1g产品价格:¥2331.00
    CAS4394-00-7
    中文名称氟尼酸
    英文名称Niflumic Acid
    别名Nifluril;Landruma;Forenol
    分子式C13H9F3N2O2
    分子量282.22
    规格100mg ; 5mg ; 10mg ; 25mg ; 50mg ; 200mg ; 500mg ; 1g
    溶解性Soluble in DMSO ≥5mg/mL
    纯度≥98%
    级别Cell Culture
    外观(性状)Light yellow to yellow Solid
    储存条件Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
    运输条件冷藏运输
    ECEINECS 224-516-2
    MDLMFCD00010569
    SMILESC1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
    InChIKeyJZFPYUNJRRFVQU-UHFFFAOYSA-N
    InChIInChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)
    PubChem CID4488
    Beilstein Number22(5)13,598
    靶点Chloride Channel
    通路Membrane Transporter&Ion Channel
    背景说明是一种钙离子激活的氯离子通道阻断剂。
    生物活性Niflumic Acid 是一种钙激活氯通道阻滞剂和 COX-2 抑制剂,其 IC50 值为 100 nM,具有抗癌活性,被用于治疗关节和肌肉疼痛。[1-5]
    IC50COX-1: 100nM(IC50)[2]
    In VitroNiflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels. Niflumic acid(10 and 30 microM)inhibited the noradrenaline and 5-HT induced increase in perfusion pressure.[1] Niflumic acid(NA),a member of the fenamates group of NSAIDs and Cl(-)and Ca(2+)-activated Cl(-)(CAC)channels blocker,induced apoptosis(by ~8 %,24 h treatment)and potentiated(by 8-10 %)apoptotic effect of endoplasmic reticulum Ca(2+)mobilizer thapsigargin(Tg)in human erythroleukemic K562 cell line.[2] Combined niflumic acid(100 和 200 μM;48 h)-ciglitazone treatment synergistically induced apoptotic cell death,activated caspase-9,caspase-3,and induced caspase-3-mediated PARP cleavage. The combination treatment also triggered apoptosis through caspase-8/Bid/Bax activation. Combined niflumic acid-ciglitazone treatment significantly induced ER stress responses.[3] Niflumic acid has proliferation-inhibiting,invasion-suppressing,cell cycle-blocking and apoptosis-promoting effects on CNE-2Z cells through regulation of ERK/MAPK.[4]
    In VivoNiflumic acid 30 mg/kg inhibited the secretory response of mucus granules in an asthma model.[5]
    数据来源文献[1]. Criddle DN,et al. Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 1997 Mar;120(5):813-8.
    [2]. Kucherenko YV,et al. Niflumic acid affects store-operated Ca(2+)-permeable (SOC) and Ca (2+)-dependent K (+) and Cl (-) ion channels and induces apoptosis in K562 cells. J Membr Biol. 2014 Jul;247(7):627-38.
    [3]. Kim BM,et al. Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells. Cancer Lett. 2011 Jan 28;300(2):134-44.
    [4]. Luo S,et al. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. Int J Clin Exp Pathol. 2015 Sep 1;8(9):9990-10001.
    [5]. Kondo M,et al. Niflumic acid inhibits goblet cell degranulation in a guinea pig asthma model. Allergol Int. 2012 Mar;61(1):133-42.
    单位
    表格1|*|1mg|5mg|10mg|$$|1mM|3.5433mL|17.7167mL|35.4333mL|$$|5mM|0.7087mL|3.5433mL|7.0867mL|$$|10mM|0.3543mL|1.7717mL|3.5433mL|

    产品细节图片1

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥550
    北京索莱宝科技有限公司
    2026年08月14日询价
    询价
    北京诺博莱德科技有限公司
    2025年11月19日询价
    询价
    上海雅心生物技术有限公司
    2026年08月30日询价
    ¥135
    翌圣生物科技(上海)股份有限公司
    2026年07月24日询价
    ¥200
    上海彩佑实业有限公司
    2025年07月14日询价
    氟尼酸
    ¥140 - 2331